Businesstoday
HOME
ECONOMY
Wholesale price inflation increases to 0.58% in November
Anti-CAA protests: CJI says rioting must stop, issues warning to Jamia students
PAN-Aadhaar linking deadline Dec 31; everything you need to know
FM Sitharaman to hold pre-Budget consultations with stakeholders
Anti-CAB protests Live updates: SC to hear Delhi Police-Jamia students' clash pleas on Tuesday; warns rioters
CORPORATE
EaseMyTrip files Rs 510 crore IPO papers with SEBI
Over 9,500 cases worth Rs 3.75 lakh crore disposed of at IBC pre-admission stage
6 of top 10 firms add Rs 65,060.30 crore in market valuation; RIL and HDFC top gainers
Mass entrepreneurs, and not just Nandan Nilekani-type of founders, should be the key focus: Skill development secretary
ArcelorMittal initiates Rs 42,000 crore payment for acquisition of debt-ridden Essar Steel
MARKETS
Rupee vs Dollar: Rupee rises 8 paise to 70.75 per dollar on US-China trade optimism
RIL arm inks Rs 25,000-crore deal with Canada's Brookfield Infra; stock nears all-time high
Share Market LIVE: Sensex, Nifty erase gains to trade flat; IT stocks gain
Sensex reclaims 41,000 mark, posts biggest single-day gain since November 25
Sensex surges 428 points, Nifty ends near 12100; 5 factors that fuelled Friday's rally
MONEY
In era of defaults, diversification can help you secure your FDs
ManipalCigna Health Insurance launches a 'super top-up' plan; should you buy?
Motilal Oswal AMC launches two index funds; should you invest?
Income tax on gifts: Know when your gift is tax-free
Should you go for new auto loan SMART EMI from ICICI Bank?
INDUSTRY
PMC Bank case: Depositors confident of recovering money after meet with CM Uddhav Thackeray
NLC India to invest Rs 17,000 crore for thermal projects in Odisha
FY20 Housing sales in 7 cities may rise by a mere 4% to 2.58 lakh units, says report
MG Motor bullish on Indian automobile sector, to invest Rs 3,000 crore
PMC Bank scam: Depositors protest outside Matoshree; meet Uddhav Thackeray
TECH
Realme sold 15 million handsets in first year of operations in India: CEO Madhav Sheth
Amazon Echo Studio review: Best smart speaker one can buy under Rs 25,000
Netflix may offer up to 50% discount on mobile-only subscription
Philips Smart Wi-Fi bulb review: Smart but not hassle-free
WhatsApp won't work on these phones from next year; check out list of devices
OPINION
FIIs and DIIs are chasing select stocks, says G Pradeepkumar on market rally
How Microfinance sector can leverage Big Data analytics for financial inclusion
Australian PM Scott Morrison India visit 2020: An opportunity for both the countries to make synergies work
AI, IoT, blockchain causing fresh threats to cyber security, says Sandeep Gupta of Protiviti
Convenience and cheaper options, why millennials are buying insurance online
photos
BT Mindrush2019: Businesses have to be disruptive or they might perish
Employees rate the best companies to work for, in 2020
These will be the top 10 most sought-after jobs in India in 2020
Here are India's 10 best-performing police stations
India ranks 129 out of 189 countries in Human Development Index 2019
Videos
11:23
Management guru Radhakrishna Pillai's tips for corporates
13:37
BT Mindrush2019: Business Today awards Best CEOs
10:01
BT MindRush 2019: Disruption is an opportunity, says Aroon Purie of India Today Group
30:41
India will become a developed nation in coming years, says Dharmendra Pradhan
49:17
BT MindRush: Experts discuss ways to disrupt the downturn
MAGAZINE
December 29, 2019
December 15, 2019
December 1, 2019
November 17, 2019
November 3, 2019
Settings
Logout
BT SPECIALS
SPECIAL ISSUES
SPECIAL REPORTS
BT BUZZ
SLOWDOWN BLUES
JOBS REALITY CHECK
UNION BUDGET
WORLD ECONOMIC FORUM
LOK SABHA ELECTION 2019
REBRAIN OR ROT
EVENTS
MAGAZINE ARCHIVES
BUSINESS TODAY
BT MORE
MONEY TODAY
GADGETS AND GIZMOS
Home
Search
Total 174 results found. Search for
[ Bayer ]
Results 120 to 140 of 174
Why some new cancer drugs are still not available in India
E. Kumar Sharma
December 7, 2013
There are more than a dozen drugs in important cancer treatment areas that are not available in India. The new drug flow into India has slowed down significantly and it is a matter of concern for oncologists and cancer patients.
BSE to rejig indices from Dec 23
PTI
Mumbai, November 23, 2013
The exchange, Asia's oldest, will include Axis Bank in the S&P BSE Sensex and Aditya Birla Nuvo in the S&P BSE 100 index effective December 23.
Govt refutes Novartis' allegations on patents
PTI
New Delhi, August 28, 2013
In reply to allegations made by Novartis on India's 'discriminatory' patent practices, the government has said global firms have benefited more from the country's rules than suffer from them.
GSK loses patent claim on breast cancer drug
PTI
Mumbai, August 2, 2013
The Intellectual Property Appellate Board (IPAB) has revoked the patent granted to the British drug major GlaxoSmithKline Pharma for its breast cancer drug Tykerb.
Bayer assess options in contraceptive case
PTI
New Delhi, April 20, 2013
German drug major Bayer AG on Friday said it \"disagrees\" with a US court ruling that allowed Indian rival Lupin to sell generic version of its oral contraceptive (OC) tablet 'Yaz' in the American market and is \"evaluating\" options.
Novartis ruling sets the tone for other patent disputes
E. Kumar Sharma
April 13, 2013
The Supreme Court decision on Glivec sets the tone for other patent disputes and puts global drugmakers on the back foot.
SC rejects Novartis patent plea for Glivec
BT Online Bureau
New Delhi, April 1, 2013
The Intellectual Property Appellate Board had denied the patent right for the drug to Novartis in 2006. The Swiss pharma major had in 2009 taken its challenge against a law that bans patents on newer forms of known drugs to the Supreme Court.
Verdict on Novartis case expected on Apr 1
E Kumar Sharma
March 28, 2013
Novartis and many companies see the final decision on Glivec, whose generic versions are currently sold in the Indian market, as a landmark judgment for it would bring clarity on the interpretation and implementation of the Indian Patents Act.
Bayer to appeal against Nexavar patent order
BT Online Bureau
March 7, 2013
Bayer AG will approach the high court in Mumbai against a ruling by Intellectual Property Appellate Board that upheld the compulsory licence issued to India's Natco Pharma to make and sell a low-cost generic of the German drug major's patented cancer drug Nexavar.
Nexavar: Patent board rejects Bayer's plea
Associated Press
New Delhi, March 5, 2013
The Intellectual Property Appellate Board has rejected Bayer AG's plea to stop Natco Pharma from producing a cheaper generic version of its patented cancer drug.
Biocon eyes Rs 100 cr from psoriasis drug
BT Online Bureau
New Delhi, January 26, 2013
Biocon is eyeing Rs 100 cr in sales in the next four years from psoriasis drug that it plans to launch under the brand Alzumab in the country in the current year.
'Minimum wages in agri sector an issue'
E Kumar Sharma
December 13, 2012
The key finding of the study is that despite the significant increase in wages in recent years in India on account of NREGA and other factors, wage rates for certain activities and categories of workers are still below legal minimum levels.
Merck loses patent for asthma drug
PTI
December 11, 2012
Indian Patents Office has revoked a patent for an asthma drug held by US-based Merck & Co following a challenge from domestic pharma firm Cipla.
Delta buys 49% stake in Virgin Atlantic
www.businesstoday.in
December 11, 2012
Sir Richard Branson will still own more than half of Virgin Atlantic, which will continue to fly as a separate airline under its own name.
Big Pharma on the backfoot in India
E. Kumar Sharma
November 29, 2012
The Intellectual Property Appellate Board's decision to deny patent protection to AstraZeneca for its lung cancer drug Gefitinib is the latest setback for global pharmaceutical companies in India.
AstraZeneca patent plea turned down again
BT Online Bureau
New Delhi, November 29, 2012
Intellectual Property Appellate Board (IPAB) has again turned down drug firm AstraZeneca's plea for a patent on the lung cancer drug Gefitinib.
What Cipla hopes to achieve in Africa through Medpro
E. Kumar Sharma
November 23, 2012
The deal, when concluded, will give Cipla more access to the region and a direct, customer-facing presence in a key export market. Medpro would be the biggest international acquisition by the company, though not the first - officials confirm that its already has stakes in some foreign companies.
Cipla slashes prices of cancer drugs
PTI
New Delhi, November 8, 2012
The pharma company slashed prices of its three generic cancer drugs - Erlocip, Docetax and Capegard - by up to 64 per cent.
Roche patent ruling may affect other cases
E. Kumar Sharma
November 4, 2012
India's Intellectual Property Appellate Board has revoked the patent granted in India to F. Hoffmann-La Roche AG (Roche) for pegylated interferon alfa-2a, a medicine used to treat hepatitis C, citing lack of evidence that the drug was better than existing treatments available in the market.
Industry watchdogs rise to the occasion
Team BT
October 9, 2012
Of late, the heads of a number of regulatory bodies have been flexing their muscles in different ways, using the full extent of their powers in a manner their predecessors had never done.
PAGES 7 OF 9
6
7
8
9
Advertisement
LATEST
Must Read
TECH NEWS
Citizenship Amendment Act: Day after Jamia clashes, Lucknow university students face off with police
Wholesale price inflation increases to 0.58% in November
Anti-CAA protests: CJI says rioting must stop, issues warning to Jamia students
Anti-CAA protests: How to check status of flights, trains to Assam, West Bengal
PAN-Aadhaar linking deadline Dec 31; everything you need to know
More
Reliance Jio Prime vs Airtel, Vodafone, Idea 4G offers
Reliance Jio plans to bring 5G internet to your smartphones
Maruti Suzuki opens online booking for Baleno RS
India Inc to get 9.5 per cent salary hike this year
Five tips to get a good salary hike this year
Realme sold 15 million handsets in first year of operations in India: CEO Madhav Sheth
Amazon Echo Studio review: Best smart speaker one can buy under Rs 25,000
Netflix may offer up to 50% discount on mobile-only subscription
Philips Smart Wi-Fi bulb review: Smart but not hassle-free
WhatsApp won't work on these phones from next year; check out list of devices
More